MA52482A - Modulateurs allostériques de spiropipéridine des récepteurs nicotiniques de l'acétylcholine - Google Patents

Modulateurs allostériques de spiropipéridine des récepteurs nicotiniques de l'acétylcholine

Info

Publication number: MA52482A
Authority: MA; Morocco
Prior art keywords: spiropiperidine; acetylcholine receptor; nicotinic acetylcholine; allosteric modulators; allosteric
Prior art date: 2018-05-01

Application number

MA052482A

Other languages

English (en)

Other versions

MA52482B1 (fr

Inventor

Ian M Bell

Brian T Campbell

Harry R Chobanian

Brendan M Crowley

James I Fells

Thomas J Greshock

Deodial G Guiadeen

Kenneth J Leavitt

Vanessa L Rada

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-05-01

Filing date

2019-04-29

Publication date

2021-03-10

2019-04-29 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2021-03-10 Publication of MA52482A publication Critical patent/MA52482A/fr

2024-12-31 Publication of MA52482B1 publication Critical patent/MA52482B1/fr

Links

JUXAVSAMVBLDKO-UHFFFAOYSA-N 1-(1-azabicyclo[2.2.2]octan-3-yl)-3-[3-(1h-indol-3-yl)-1-oxo-1-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylpropan-2-yl]urea Chemical compound C1N(CC2)CCC2C1NC(=O)NC(C(=O)N1CCC2(C3=CC=CC=C3CC2)CC1)CC1=CNC2=CC=CC=C12 JUXAVSAMVBLDKO-UHFFFAOYSA-N 0.000 title 1
102000019315 Nicotinic acetylcholine receptors Human genes 0.000 title 1
108050006807 Nicotinic acetylcholine receptors Proteins 0.000 title 1
230000003281 allosteric effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MA52482A 2018-05-01 2019-04-29 Dérivés de spiropipéridine en tant que modulateurs allostériques des récepteurs nicotiniques de l'acétylcholine MA52482B1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201862665091P	2018-05-01	2018-05-01
EP19722488.4A EP3788043B1 (fr)	2018-05-01	2019-04-29	Dérivés de spiropipéridine en tant que modulateurs allostériques des récepteurs nicotiniques de l'acétylcholine
PCT/US2019/029561 WO2019212927A1 (fr)	2018-05-01	2019-04-29	Modulateurs allostériques de spiropipéridine des récepteurs nicotiniques de l'acétylcholine

Publications (2)

Publication Number	Publication Date
MA52482A true MA52482A (fr)	2021-03-10
MA52482B1 MA52482B1 (fr)	2024-12-31

Family

ID=66429709

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA52482A MA52482B1 (fr)	2018-05-01	2019-04-29	Dérivés de spiropipéridine en tant que modulateurs allostériques des récepteurs nicotiniques de l'acétylcholine

Country Status (39)

Country	Link
US (1)	US11332463B2 (fr)
EP (1)	EP3788043B1 (fr)
JP (1)	JP7073533B2 (fr)
KR (1)	KR102587811B1 (fr)
CN (1)	CN112119076B (fr)
AR (1)	AR115065A1 (fr)
AU (1)	AU2019262917B2 (fr)
BR (1)	BR112020022088A8 (fr)
CA (1)	CA3098583C (fr)
CL (2)	CL2020002820A1 (fr)
CO (1)	CO2020013462A2 (fr)
CR (1)	CR20200509A (fr)
DK (1)	DK3788043T3 (fr)
EA (1)	EA202092608A1 (fr)
EC (1)	ECSP20067907A (fr)
ES (1)	ES2995040T3 (fr)
FI (1)	FI3788043T3 (fr)
GE (2)	GEP20227409B (fr)
HR (1)	HRP20241704T1 (fr)
HU (1)	HUE070339T2 (fr)
IL (1)	IL278154B2 (fr)
JO (1)	JOP20200272A1 (fr)
LT (1)	LT3788043T (fr)
MA (1)	MA52482B1 (fr)
MD (1)	MD3788043T2 (fr)
MX (1)	MX2020011489A (fr)
MY (1)	MY205690A (fr)
NI (1)	NI202000074A (fr)
PE (1)	PE20210052A1 (fr)
PH (1)	PH12020551779A1 (fr)
PL (1)	PL3788043T3 (fr)
PT (1)	PT3788043T (fr)
RS (1)	RS66290B1 (fr)
SG (1)	SG11202010459XA (fr)
SI (1)	SI3788043T1 (fr)
TW (1)	TWI839355B (fr)
UA (1)	UA126834C2 (fr)
WO (1)	WO2019212927A1 (fr)
ZA (1)	ZA202006507B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10357493B2 (en)	2017-03-10	2019-07-23	Selenity Therapeutics (Bermuda), Ltd.	Metalloenzyme inhibitor compounds
US12331022B2 (en) *	2019-05-02	2025-06-17	Merck Sharp & Dohme Llc	Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
CN114727974A (zh)	2019-07-30	2022-07-08	艾科尼佐治疗股份有限公司	Hdac6抑制剂及其用途
US12534458B2 (en) *	2019-11-05	2026-01-27	Merck Sharp & Dohme Llc	Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
BR112022012153A2 (pt)	2019-12-19	2022-08-30	Curia Spain S A U	Processo para preparar um composto e composto
WO2022169985A1 (fr)	2021-02-03	2022-08-11	Eikonizo Therapeutics, Inc.	Inhibiteurs de hdac6 et leurs utilisations
AU2023250964A1 (en)	2022-04-08	2024-11-07	Eikonizo Therapeutics, Inc.	Oxadiazole hdac6 inhibitors and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CL2004000754A1 (es)	2003-04-11	2005-02-25	Janssen Pharmaceutica Nv	Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central.
KR101178674B1 (ko)	2007-10-04	2012-08-30	에프. 호프만-라 로슈 아게	사이클로프로필 아릴 아마이드 유도체 및 이의 용도
KR101925971B1 (ko)	2011-01-28	2018-12-06	에스케이바이오팜 주식회사	피리돈 유도체 및 이를 포함하는 약학적 조성물
AU2012212393B2 (en)	2011-02-02	2015-06-11	Bionomics Limited	Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof.
UA111746C2 (uk)	2011-07-08	2016-06-10	Х. Луннбек А/С	Позитивні алостеричні модулятори нікотинового рецептора ацетилхоліну
HRP20180913T1 (hr)	2011-07-08	2018-07-27	H. Lundbeck A/S	Pozitivni alosterni modulatori receptora nikotinskog acetilkolina
WO2014006120A1 (fr)	2012-07-06	2014-01-09	H. Lundbeck A/S	Nouveaux modulateurs allostériques positifs de récepteur nicotinique à l'acétylcholine
EP2888229B1 (fr)	2012-08-01	2019-02-06	Merck Sharp & Dohme Corp.	MODULATEURS DU RÉCEPTEUR alpha7 NICOTINIQUE D'ACÉTYLCHOLINE ET LEURS UTILISATIONS
MX2015004285A (es) *	2012-10-02	2015-08-06	Sumitomo Dainippon Pharma Co Ltd	Derivado de imidazol.
EP2928860A1 (fr)	2012-12-10	2015-10-14	H. Lundbeck A/S	Nouveaux modulateurs allostériques positifs d'un récepteur nicotinique de l'acétylcholine
US10208081B2 (en)	2014-11-26	2019-02-19	Enanta Pharmaceuticals, Inc.	Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
CN110072864B (zh)	2015-12-24	2022-05-27	基因泰克公司	Tdo2抑制剂
US9840481B2 (en) *	2016-03-22	2017-12-12	Merck Sharp & Dohme Corp.	Allosteric modulators of nicotinic acetylcholine receptors

2019
- 2019-04-29 JO JOP/2020/0272A patent/JOP20200272A1/ar unknown
- 2019-04-29 AU AU2019262917A patent/AU2019262917B2/en active Active
- 2019-04-29 CR CR20200509A patent/CR20200509A/es unknown
- 2019-04-29 MA MA52482A patent/MA52482B1/fr unknown
- 2019-04-29 TW TW108114867A patent/TWI839355B/zh active
- 2019-04-29 EP EP19722488.4A patent/EP3788043B1/fr active Active
- 2019-04-29 AR ARP190101126A patent/AR115065A1/es unknown
- 2019-04-29 US US17/049,653 patent/US11332463B2/en active Active
- 2019-04-29 DK DK19722488.4T patent/DK3788043T3/da active
- 2019-04-29 LT LTEPPCT/US2019/029561T patent/LT3788043T/lt unknown
- 2019-04-29 HU HUE19722488A patent/HUE070339T2/hu unknown
- 2019-04-29 UA UAA202007589A patent/UA126834C2/uk unknown
- 2019-04-29 WO PCT/US2019/029561 patent/WO2019212927A1/fr not_active Ceased
- 2019-04-29 MY MYPI2020005673A patent/MY205690A/en unknown
- 2019-04-29 FI FIEP19722488.4T patent/FI3788043T3/fi active
- 2019-04-29 SI SI201930865T patent/SI3788043T1/sl unknown
- 2019-04-29 CA CA3098583A patent/CA3098583C/fr active Active
- 2019-04-29 KR KR1020207034124A patent/KR102587811B1/ko active Active
- 2019-04-29 EA EA202092608A patent/EA202092608A1/ru unknown
- 2019-04-29 PE PE2020001722A patent/PE20210052A1/es unknown
- 2019-04-29 CN CN201980029616.2A patent/CN112119076B/zh active Active
- 2019-04-29 IL IL278154A patent/IL278154B2/en unknown
- 2019-04-29 PT PT197224884T patent/PT3788043T/pt unknown
- 2019-04-29 GE GEAP201915499A patent/GEP20227409B/en unknown
- 2019-04-29 PL PL19722488.4T patent/PL3788043T3/pl unknown
- 2019-04-29 SG SG11202010459XA patent/SG11202010459XA/en unknown
- 2019-04-29 BR BR112020022088A patent/BR112020022088A8/pt unknown
- 2019-04-29 ES ES19722488T patent/ES2995040T3/es active Active
- 2019-04-29 GE GEAP202215499A patent/GEAP202215499A/en unknown
- 2019-04-29 RS RS20241372A patent/RS66290B1/sr unknown
- 2019-04-29 MD MDE20210207T patent/MD3788043T2/ro unknown
- 2019-04-29 HR HRP20241704TT patent/HRP20241704T1/hr unknown
- 2019-04-29 MX MX2020011489A patent/MX2020011489A/es unknown
- 2019-04-29 JP JP2020560807A patent/JP7073533B2/ja active Active
2020
- 2020-10-20 ZA ZA2020/06507A patent/ZA202006507B/en unknown
- 2020-10-26 EC ECSENADI202067907A patent/ECSP20067907A/es unknown
- 2020-10-26 CO CONC2020/0013462A patent/CO2020013462A2/es unknown
- 2020-10-27 PH PH12020551779A patent/PH12020551779A1/en unknown
- 2020-10-27 NI NI202000074A patent/NI202000074A/es unknown
- 2020-10-29 CL CL2020002820A patent/CL2020002820A1/es unknown
2021
- 2021-07-06 CL CL2021001795A patent/CL2021001795A1/es unknown

Also Published As

Publication number	Publication date
LT3788043T (lt)	2024-12-27
WO2019212927A1 (fr)	2019-11-07
TWI839355B (zh)	2024-04-21
CO2020013462A2 (es)	2020-11-10
CL2020002820A1 (es)	2021-02-19
JP2021523102A (ja)	2021-09-02
EP3788043A1 (fr)	2021-03-10
IL278154A (en)	2020-11-30
IL278154B1 (en)	2025-02-01
US11332463B2 (en)	2022-05-17
GEP20227409B (en)	2022-09-12
FI3788043T3 (fi)	2025-01-15
MY205690A (en)	2024-11-06
CA3098583A1 (fr)	2019-11-07
JP7073533B2 (ja)	2022-05-23
KR20210005697A (ko)	2021-01-14
NI202000074A (es)	2021-03-05
CN112119076A (zh)	2020-12-22
PL3788043T3 (pl)	2025-03-10
MD3788043T2 (ro)	2025-03-31
MA52482B1 (fr)	2024-12-31
HRP20241704T1 (hr)	2025-02-14
NZ768954A (en)	2025-06-27
AR115065A1 (es)	2020-11-25
EA202092608A1 (ru)	2021-03-02
BR112020022088A2 (pt)	2021-02-02
CN112119076B (zh)	2025-01-10
SG11202010459XA (en)	2020-11-27
HUE070339T2 (hu)	2025-05-28
DK3788043T3 (da)	2024-12-16
SI3788043T1 (sl)	2025-01-31
AU2019262917A1 (en)	2020-11-05
KR102587811B1 (ko)	2023-10-11
IL278154B2 (en)	2025-06-01
BR112020022088A8 (pt)	2023-02-07
UA126834C2 (uk)	2023-02-08
MX2020011489A (es)	2020-12-07
PH12020551779A1 (en)	2021-06-07
PT3788043T (pt)	2024-12-03
AU2019262917B2 (en)	2021-12-23
GEAP202215499A (en)	2022-05-10
US20210070745A1 (en)	2021-03-11
CL2021001795A1 (es)	2021-12-24
CR20200509A (es)	2020-12-23
CA3098583C (fr)	2023-05-16
JOP20200272A1 (ar)	2020-11-01
ZA202006507B (en)	2025-06-25
RS66290B1 (sr)	2025-01-31
ECSP20067907A (es)	2021-02-26
TW202014419A (zh)	2020-04-16
PE20210052A1 (es)	2021-01-08
ES2995040T3 (en)	2025-02-05
EP3788043B1 (fr)	2024-11-06

Publication	Publication Date	Title
MA43756A (fr)	2021-05-19	Modulateurs allostériques des récepteurs nicotiniques de l'acétylcholine
EP3474846A4 (fr)	2019-12-04	Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4
EP3416639A4 (fr)	2019-07-03	Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m1
EP3684357A4 (fr)	2021-01-20	Modulateurs allostériques hétéroaryliques des récepteurs nicotiniques de l'acétylcholine
IL278154A (en)	2020-11-30	Spiropiperidine compounds as allosteric modulators of nicotinic acetylcholine receptors
MA51337A (fr)	2020-10-28	Inhibiteurs spiro exo-aza de l'interaction ménine-mll
EP3962483A4 (fr)	2023-01-25	Modulateurs allostériques de spiropipéridine de récepteurs nicotiniques de l'acétylcholine
EP3408372A4 (fr)	2019-10-02	Aliquotage microfluidique pour l'isolement de cellules individuelles
EP3558946A4 (fr)	2020-05-27	Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4
EP3534901A4 (fr)	2020-04-22	Modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4
MA49564A (fr)	2021-04-28	Modulateurs thérapeutiques du mode inverse de l'atp synthase
EP3801642A4 (fr)	2022-03-23	Compositions de cellules de récepteur d'auto-anticorps chimérique kinase à spécificité musculaire et méthodes correspondantes
EP3644990A4 (fr)	2021-03-10	Modulateurs allostériques de type 5-(pyridin-3-yl)oxazole du récepteur muscarinique m4 d'acétylcholine
MA46899A (fr)	2021-04-14	Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4
MA47126A (fr)	2019-10-30	Modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4
EP3873467A4 (fr)	2022-07-06	Modulateurs allostériques 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
EP3534889A4 (fr)	2020-05-06	Modulateurs allostériques aryle ou hétéroaryle à 6 chaînons substitués de récepteurs nicotiniques de l'acétylcholine
MA51036A (fr)	2021-03-17	Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4
EP3534888A4 (fr)	2020-05-06	Modulateurs allostériques hétéroaryle bicycliques substitués de récepteurs nicotiniques de l'acétylcholine
MA51038A (fr)	2020-10-14	Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4
DK3743043T3 (da)	2024-09-02	Farmaceutiske sammensætninger til behandling af post-operative smerter
EP4054569A4 (fr)	2023-10-25	Modulateurs allostériques de spiropipéridine de récepteurs nicotiniques de l'acétylcholine
HK40038649A (en)	2021-06-25	Positive allosteric modulators of the muscarinic acetylcholine receptor m4
HK40039227A (en)	2021-07-09	Positive allosteric modulators of the muscarinic acetylcholine receptor m4
HK40015440A (en)	2020-08-28	Positive allosteric modulators of the muscarinic acetylcholine receptor m4